These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6725599)

  • 1. A quantitative study of mast cells in Hodgkin's disease.
    Crocker J; Smith PJ
    J Clin Pathol; 1984 May; 37(5):519-22. PubMed ID: 6725599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cells which contain S-100 protein in Hodgkin's disease: a quantitative study.
    Sangster G; Crocker J; Jenkins R; Leyland MJ
    J Clin Pathol; 1985 Sep; 38(9):1021-4. PubMed ID: 3900142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cell reactivity in lymphoma: a preliminary communication.
    Sharma VK; Agrawal A; Pratap VK; Nagar AM; Mehrotra ML
    Indian J Cancer; 1992 Jun; 29(2):61-5. PubMed ID: 1473834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mastocytes in Hodgkin's lymphoma].
    Pastrnák A; Jansa P
    Cesk Patol; 1987 Sep; 23(3):162-4. PubMed ID: 3664718
    [No Abstract]   [Full Text] [Related]  

  • 5. Focal changes of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) associated with nodular lymphocyte predominant Hodgkin's disease.
    Maia DM; Dorfman RF
    Hum Pathol; 1995 Dec; 26(12):1378-82. PubMed ID: 8522313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ammoniacal silver staining of lymph node cells. II. Reactive follicular hyperplasia and its relationship with Hodgkin's disease.
    Rengifo E; Quintero S; Marinello Z
    Neoplasma; 1985; 32(6):741-4. PubMed ID: 2418374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease.
    Borg-Grech A; Radford JA; Crowther D; Swindell R; Harris M
    J Clin Oncol; 1989 Sep; 7(9):1303-9. PubMed ID: 2769329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ultrastructural identification of tissue basophils and mast cells in Hodgkin's disease.
    Parmley RT; Spicer SS; Wright NJ
    Lab Invest; 1975 Apr; 32(4):469-75. PubMed ID: 1127869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro sensitivity of Hodgkin's disease to hydrogen peroxide toxicity. Correlation with peroxidase activity.
    Samoszuk MK; Rietveld C; Gidanian F; Petersen A
    Cancer; 1989 Jun; 63(11):2111-4. PubMed ID: 2541883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological Studies in Hodgkin's disease.
    Elsner B
    Beitr Pathol; 1975 Nov; 156(2):101-8. PubMed ID: 1212162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers.
    Burns BF; Colby TV; Dorfman RF
    Am J Surg Pathol; 1984 Apr; 8(4):253-61. PubMed ID: 6369997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytological basis of histological typing of diffuse Hodgkin's disease. Demonstration of an implied misnomer in the terminology of the Rye classification.
    Livesey AE; Sutherland FI; Brown RA; Beck JS; Macgillivray JB; Slidders W
    J Clin Pathol; 1978 Jun; 31(6):551-9. PubMed ID: 670411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease.
    Jack AS; Cunningham D; Soukop M; Liddle CN; Lee FD
    J Clin Pathol; 1986 Mar; 39(3):267-70. PubMed ID: 3514684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
    Andersen MD; Kamper P; Nielsen PS; Bendix K; Riber-Hansen R; Steiniche T; Hamilton-Dutoit S; Clausen M; d'Amore F
    Eur J Haematol; 2016 Mar; 96(3):252-9. PubMed ID: 25963595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tryptase- and chymase-positive mast cells as possible prognostic factor in patients with Hodgkin's lymphoma].
    Rygoł B; Kyrcz-Krzemień S; Pajiak J; Konicki P; Kowai E; Gasińska T
    Pol Arch Med Wewn; 2007; 117(1-2):27-32. PubMed ID: 17642203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative study of alpha-naphthyl acetate esterase-positive cells in Hodgkin's disease.
    Crocker J; Jones EL; Curran RC
    J Clin Pathol; 1982 Dec; 35(12):1301-6. PubMed ID: 6757271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte predominant Hodgkin's disease of nodular subtype combined with pulmonary lymphoid infiltration and hypogammaglobulinaemia.
    Li G; Hansmann ML
    Virchows Arch A Pathol Anat Histopathol; 1989; 415(5):481-7. PubMed ID: 2508307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localisation of factor VIII-related antigen in Hodgkin's disease.
    Crocker J; Smith PJ
    J Clin Pathol; 1984 Jan; 37(1):37-44. PubMed ID: 6423698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma.
    Molin D; Edström A; Glimelius I; Glimelius B; Nilsson G; Sundström C; Enblad G
    Br J Haematol; 2002 Oct; 119(1):122-4. PubMed ID: 12358914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type IV collagen in Hodgkin's disease. An immunohistochemical study.
    Crocker J; Overton SP; Smith PJ
    Am J Clin Pathol; 1988 Jan; 89(1):57-62. PubMed ID: 3122556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.